前沿生物：公司构建了涵盖研发、临床、生产、商业化的全产业链体系

Core Viewpoint - The company, Frontline Bio, emphasizes its innovative gene and comprehensive capabilities in the biopharmaceutical industry, positioning itself as a research-driven innovative drug enterprise rather than merely a biotech R&D firm [1] Group 1: Company Structure and Strategy - The company has established a complete industry chain system that includes R&D, clinical trials, production, and commercialization, enhancing its overall competitive strength [1] - This comprehensive layout strengthens the company's capabilities in product decision-making, efficient R&D advancement, and value conversion of results, providing solid support for the continuous development of its pipeline [1] Group 2: Product Development Focus - In the small nucleic acid pipeline, the company focuses on superior clinical efficacy and differentiated competitive advantages as core guiding principles [1] - The products launched, including dual-target products, are developed around the goal of achieving better clinical outcomes [1] - The company emphasizes a deep analysis and precise understanding of disease mechanisms during target selection, aiming for superior clinical efficacy and focusing on dual-target products with synergistic effects and significant differentiation advantages [1]